Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been newly diagnosed with a specific type of brain tumour called IDH-wildtype glioblastoma
- People who have completed surgery to remove as much of the brain tumour as was safely possible
- People who have completed radiation therapy to the brain after surgery
- People for whom the treating doctor plans to proceed with up to 6 cycles of a chemotherapy called TMZ, starting within 8 weeks of finishing radiation therapy
- People who are able and willing to give their agreement to participate in the study
Who may not be able to join:
- People who are unable or unwilling to complete study questionnaires
- People who have another cancer that has spread or cannot be cured, separate from the IDH-wildtype glioblastoma diagnosis
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Terry Ng, MD, The Ottawa Hospital Cancer Centre
Phone: 613-737-7700
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility: adherence to TMZ dose timing protocol
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.